394 related articles for article (PubMed ID: 27814820)
61. Utility of short-interval follow-up mammography after a benign-concordant stereotactic breast biopsy result.
Maldonado S; Gandhi N; Ha T; Choi P; Khalkhali I; Kalantari BN; Dauphine C
Breast; 2018 Dec; 42():50-53. PubMed ID: 30172804
[TBL] [Abstract][Full Text] [Related]
62. [Cost-effectiveness of an organized breast cancer screening program in Southern Brazil].
Ribeiro RA; Caleffi M; Polanczyk CA
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S131-45. PubMed ID: 25402242
[TBL] [Abstract][Full Text] [Related]
63. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Ahern CH; Shen Y
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):718-25. PubMed ID: 19258473
[TBL] [Abstract][Full Text] [Related]
64. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
65. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
[TBL] [Abstract][Full Text] [Related]
66. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
[TBL] [Abstract][Full Text] [Related]
67. MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.
Emaus MJ; Bakker MF; Peeters PH; Loo CE; Mann RM; de Jong MD; Bisschops RH; Veltman J; Duvivier KM; Lobbes MB; Pijnappel RM; Karssemeijer N; de Koning HJ; van den Bosch MA; Monninkhof EM; Mali WP; Veldhuis WB; van Gils CH
Radiology; 2015 Nov; 277(2):527-37. PubMed ID: 26110667
[TBL] [Abstract][Full Text] [Related]
68. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
[TBL] [Abstract][Full Text] [Related]
69. Cost-effectiveness of breast cancer screening in Spain.
Plans P; Casademont L; Salleras L
Int J Technol Assess Health Care; 1996; 12(1):146-50. PubMed ID: 8690555
[TBL] [Abstract][Full Text] [Related]
70. Specificity of screening in United Kingdom trial of early detection of breast cancer.
BMJ; 1992 Feb; 304(6823):346-9. PubMed ID: 1540731
[TBL] [Abstract][Full Text] [Related]
71. Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain.
Domingo L; Hofvind S; Hubbard RA; Román M; Benkeser D; Sala M; Castells X
Eur Radiol; 2016 Aug; 26(8):2520-8. PubMed ID: 26560729
[TBL] [Abstract][Full Text] [Related]
72. Understanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United States.
Kunst N; Long JB; Xu X; Busch SH; Kyanko KA; Lindau ST; Richman IB; Gross CP
Med Care; 2021 May; 59(5):437-443. PubMed ID: 33560712
[TBL] [Abstract][Full Text] [Related]
73. Serendipity in diagnostic imaging: magnetic resonance imaging of the breast.
Lawrence WF; Liang W; Mandelblatt JS; Gold KF; Freedman M; Ascher SM; Trock BJ; Chang P
J Natl Cancer Inst; 1998 Dec; 90(23):1792-800. PubMed ID: 9839519
[TBL] [Abstract][Full Text] [Related]
74. Cost-Effectiveness Analysis of Breast Cancer Screening in Rural Iran.
Zehtab N; Jafari M; Barooni M; Nakhaee N; Goudarzi R; Larry Zadeh MH
Asian Pac J Cancer Prev; 2016; 17(2):609-14. PubMed ID: 26925651
[TBL] [Abstract][Full Text] [Related]
75. Evolution of breast cancer screening in the Medicare population: clinical and economic implications.
Killelea BK; Long JB; Chagpar AB; Ma X; Wang R; Ross JS; Gross CP
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031307
[TBL] [Abstract][Full Text] [Related]
76. Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.
Salikhanov I; Crape B; Howie P
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3153-3160. PubMed ID: 31653167
[TBL] [Abstract][Full Text] [Related]
77. Screening mammography and public health policy: the need for perspective.
Wright CJ; Mueller CB
Lancet; 1995 Jul; 346(8966):29-32. PubMed ID: 7603143
[TBL] [Abstract][Full Text] [Related]
78. A cost utility analysis of mammography screening in Australia.
Hall J; Gerard K; Salkeld G; Richardson J
Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
[TBL] [Abstract][Full Text] [Related]
79. Should low-income countries invest in breast cancer screening?
Gyawali B; Shimokata T; Honda K; Tsukuura H; Ando Y
Cancer Causes Control; 2016 Nov; 27(11):1341-1345. PubMed ID: 27680017
[TBL] [Abstract][Full Text] [Related]
80. Cost-effectiveness of breast cancer screening programme for women in rural China.
Sun L; Sadique Z; Dos-Santos-Silva I; Yang L; Legood R
Int J Cancer; 2019 May; 144(10):2596-2604. PubMed ID: 30367451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
